What is Patrick Soon-Shiong’s net worth?
Patrick Soon-net Shiong’s worth is predicted to be around $10 billion as of November 2022.
Net Worth: |
$10 Billion |
|---|---|
Age: |
70 |
Born: |
January 1, 1952 |
Gender: |
Male |
Height: |
Unknown |
Country of Origin: |
South Africa |
Source of Wealth: |
Entrepreneur |
Last Updated: |
Nov 4, 2022 |
Introduction
South African-American transplant surgeon and multimillionaire Patrick Soon-Shiong.
The medicine Abraxane, developed by Soon-Shiong, gained notoriety for its effectiveness against pancreatic, breast, and lung cancer. He is the creator of NantWorks, a network of entrepreneurs focused on biotechnology, artificial intelligence, and healthcare.
He has more than 230 issued patents globally covering innovations in many different areas of technology and medicine, and he has published more than 100 scientific articles.
Patrick Soon-net Shiong’s worth is predicted to be around $10 billion as of November 2022.
Early Years
On July 29, 1952, Patrick Soon-Shiong was born in Port Elizabeth, South Africa.
The parents of Soon-Shiong, a Chinese immigrant, fled their home country during the Japanese occupation of China in World War II.
He received his University of Witwatersrand diploma in fourth place among his peers. At the age of 23, Soon-Shiong earned a bachelor’s degree in medicine. The General Hospital in Johannesburg is where he finished his internship in medicine. He continued his education at the University of British Columbia, where he graduated in 1979 with a master’s degree.
you may like: Philip Lawrence Net Worth – $50 Million
Career
Soon-Shiong left UCLA in 1991 and started the biotechnology business Abraxis BioScience. Under his direction, the business eventually produced a ground-breaking medication used to treat breast, lung, and pancreatic cancer.
When chemotherapy failed to treat breast cancer, the FDA approved the medication Abraxane in 2005, and the European equivalent followed suit in 2008.
Every year, $315 million was made by Abraxane. In 2010, American biotech corporation Celgene paid $3 billion in cash and stock to purchase Soon-exclusively Shiong’s owned Abraxis BioScience.
In 1997, he established a business called American Pharmaceutical Partners, which was one of his major triumphs.
By 2008, APP was bringing in $750 million annually, of which about $300 million was pure profit. Fresenius SE, situated in Homberg, Germany, agreed to buy APP in July 2008 for $5.6 billion.
In 2011, he also started a another business named NantWorks. The health subsidiary of Nantworks, NantHealth, promises to supply cloud-based data to the healthcare sector.
Patrick Soon-net Shiong’s worth is predicted to be around $10 billion as of November 2022.
What is Patrick Soon-Money Shiong’s Used For?
Real estate is where Patrick Soon-Shiong invests his money.
Home of Patrick Soon-Shiong
Soon-Shiong is the owner of a stunning residence in Los Angeles, California.
Highlights
Here are some of the best highlights of Patrick Soon-Shiong’s career:
- He is the inventor of the drug Abraxane
- Soon-Shiong is the founder of NantWorks
- Soon-Shiong joined UCLA Medical School (1983)
Favorite Quotes from Patrick Soon-Shiong
“Cancer is really a slew of rare diseases. Lung cancer has 700 sub-types. Breast cancer has 30,000 mutations which means that every cancer in its own right is a rare disease. Sharing data globally in this context is really important from a life-threatening perspective.” – Patrick Soon-Shiong
“Baseball is like cricket, and I grew up in a country where they had cricket. So I understand cricket, soccer, and basketball. I played basketball at the club level and a little bit in college, so that’s why Im a basketball fanatic.” – Patrick Soon-Shiong
“If you look upon chronic diseases as an epidemic, and you see that the chronically ill are the poor, then you see that this issue of the uninsured is not really a moral but a financial obligation to change health care.” – Patrick Soon-Shiong
“I was working with stem cells as part of a NASA programme. We realised that the science of stem-cell proliferation was also fundamental to cancer cells when cancer enters the phase of metastasis.” – Patrick Soon-Shiong
“My goal is to build standards that would meet world standards such as in the US or Europe and make the products in SA so that the country becomes the exporter of next-generation biologic drugs for cancer and infectious diseases. That’s not an impossible dream, and I think it could be accomplished within five years.” – Patrick Soon-Shiong
3 Life Lessons from Patrick Soon-Shiong
Let’s look at some of the things we can learn from Patrick Soon-Shiong now that you are fully aware of his net worth and the path to success:
1. The Physical World
A sensor and machine vision browser for the real world is called iD. In order to activate content when a picture is detected, Soon-Shiong has been collaborating with Coca-Cola, Verizon, Bank of America, and Disney.
2. New Diagnoses
With 13 million cancer survivors and roughly 2 million new cancer diagnoses each year, the United States has about 10,000 patients who need analysis each day. That amounts to daily computation and transmission requirements of around five petabytes.
3. Play and Live
Every consumer is a potential patient, just as every patient is a prospective consumer. NantWorks is creating the world as Da Vinci envisioned it and enhancing each frame a person sees while they are at work, home, or playing.
Frequently Asked Questions
How much is Patrick Soon-Shiong worth?
Patrick Soon-Shiong’s net worth is estimated to be $10 Billion.
How old is Patrick Soon-Shiong?
Patrick Soon-Shiong was born on January 1, 1952, and is currently 70 years old.
How tall is Patrick Soon-Shiong?
Patrick Soon-Shiong’s height is Unknown.
Summary
South African-born surgeon and drug inventor Patrick Soon-Shiong was born.
He ranks among the wealthiest residents of Los Angeles. Soon-Shiong bought Magic Johnson’s 4.5% ownership interest in the Los Angeles Lakers in 2010.
He is the principal non-Buss family owner of the Lakers. Soon-Shiong graduated with a Master of Science from the University of British Columbia as a young man. He was a faculty member at the UCLA Medical School from 1983 to 1991, and he has more than 50 patents to his name.
